Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclosporin: use outside transplantation.

Literature DB >> 1991188

Cyclosporin: use outside transplantation.

A W Thomson, G H Neild.

Abstract

Entities: Chemical

Mesh：

Substances：
Cyclosporins

Year: 1991 PMID： 1991188 PMCID： PMC1668781 DOI： 10.1136/bmj.302.6767.4

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

10 in total

1. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

Authors: P Tugwell; C Bombardier; M Gent; K J Bennett; W G Bensen; S Carette; A Chalmers; J M Esdaile; A V Klinkhoff; G R Kraag
Journal: Lancet Date: 1990-05-05 Impact factor: 79.321

Review 2. Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine.

Authors: B Ryffel
Journal: Pharmacol Rev Date: 1990-09 Impact factor: 25.468

Review 3. Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo.

Authors: J F Borel
Journal: Pharmacol Rev Date: 1990-09 Impact factor: 25.468

4. Signal transmission pathways and lymphocyte function.

Authors: R B Gallagher; J C Cambier
Journal: Immunol Today Date: 1990-06

5. Contingent genetic regulatory events in T lymphocyte activation.

Authors: G R Crabtree
Journal: Science Date: 1989-01-20 Impact factor: 47.728

6. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

Authors: J Brynskov; L Freund; S N Rasmussen; K Lauritsen; O S de Muckadell; N Williams; A S MacDonald; R Tanton; F Molina; M C Campanini
Journal: N Engl J Med Date: 1989-09-28 Impact factor: 91.245

7. FK 506 for liver, kidney, and pancreas transplantation.

Authors: T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal: Lancet Date: 1989-10-28 Impact factor: 79.321

8. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.

Authors: R H Wiesner; J Ludwig; K D Lindor; R A Jorgensen; W P Baldus; H A Homburger; E R Dickson
Journal: N Engl J Med Date: 1990-05-17 Impact factor: 91.245

9. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis.

Authors: R S Tindall; J A Rollins; J T Phillips; R G Greenlee; L Wells; G Belendiuk
Journal: N Engl J Med Date: 1987-03-19 Impact factor: 91.245

10. Lymphokine gene expression in vivo is inhibited by cyclosporin A.

Authors: A Granelli-Piperno
Journal: J Exp Med Date: 1990-02-01 Impact factor: 14.307

10 in total

8 in total

Review 1. Cyclosporin for Crohn's disease?

Authors: M Guslandi; A Tittobello
Journal: Drugs Date: 1992-04 Impact factor: 9.546

Review 2. The spectrum of action of new immunosuppressive drugs.

Authors: A W Thomson
Journal: Clin Exp Immunol Date: 1992-08 Impact factor: 4.330

3. Tuberculosis and HIV infection.

Authors: J Wright; H Ford
Journal: BMJ Date: 1991-06-29

4. Monitoring cyclosporin treatment.

Authors: C Speed
Journal: BMJ Date: 1993-02-06

Review 5. Lupus therapy.

Authors: H Baart de la Faille
Journal: Clin Investig Date: 1994-10

Review 6. A review of assay methods for cyclosporin. Clinical implications.

Authors: K T Kivistö
Journal: Clin Pharmacokinet Date: 1992-09 Impact factor: 6.447

7. Biopharmaceutical Evaluation of Novel Cyclosporine A Nano-matrix Particles for Inhalation.

Authors: Hideyuki Sato; Hiroki Suzuki; Keisuke Yakushiji; Jennifer Wong; Yoshiki Seto; Robert K Prud'homme; Hak-Kim Chan; Satomi Onoue
Journal: Pharm Res Date: 2016-05-25 Impact factor: 4.200

8. PLA₂-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy.

Authors: Milica Markovic; Shimon Ben-Shabat; Jagadeesh Nagendra Manda; Karina Abramov-Harpaz; Clil Regev; Yifat Miller; Aaron Aponick; Ellen M Zimmermann; Arik Dahan
Journal: Pharmaceutics Date: 2022-03-18 Impact factor: 6.321

8 in total